To examine the effects of HI-TOPK-032 (an agonist that binds to the active site of PBK [28], cells from each of the three GIC cultures were treated with 5 μM and 10 μM HI-TOPK-032, concentrations shown previously to efficiently inhibit PBK in other cancer cell lines [28]. Here, PBK is linked to cancer.